Symbiota™ 217

Microbiome-Driven Detox & Gut-Liver Axis Regulator

Protect the Liver from Gut-Derived Toxins

Liver stress often begins in the gut. When the intestinal barrier is compromised, toxins travel directly to the liver via the portal vein. Symbiota™ 217 is a precision-fermented metabiotic ingredient designed to intercept this process. It modulates the gut-liver axis to reduce endotoxin burden and protect against metabolic liver dysfunction.

Core Mechanisms & Clinical Highlights

  • Endotoxin Load Reduction: Reinforces the intestinal barrier, preventing gut-derived toxins (leaky gut) from triggering systemic inflammation.
  • Liver Health Support: Supported by NASH animal models and human microbiome analysis, demonstrating significant reductions in inflammatory signaling associated with liver stress.
  • Microbiota Reshaping: Promotes beneficial bacteria (such as Roseburia hominis) to increase SCFA production, establishing a healthy gut lumen environment.

What Makes Symbiota™ 217 Different?

Precision Symbiotic Fermentation Technology

Powered by the proprietary Symbiota™ platform, Symbiota™217 utilizes multi-strain symbiotic fermentation to generate complex bioactive metabolites through microbial cross-talk and metabolic interactions.

Key Technology Advantages

  • Multi-strain synergy
  • Complete metabolite profile
  • Nano-sized metabolites
  • Stable & flexible formulation
  • Over 20 international patents
  • More than 1,600 microbial solution libraries

Three Key Benefits of Symbiota™ 217

Three Key Benefits of Symbiota™ 217

Scientific Evidence Supporting Symbiota™ 217

1. Microbiome Reset & Rebalance
Indicating a measurable rebalancing of the gut microbiota toward a healthier profile.

  • Roseburia hominis
  • Subdoligranulum
  • Klebsiella pneumoniae
  • Escherichia coli
  • Desulfovibrionaceae

2.Gut Barrier Enhancement

3.Hepatic Inammation Modulation

4.Liver Health Improvement

Request More Information Symbiota_217